[1]
Guo, H. et al. 2015. Synthesis and Biological Evaluation of 1,2,3,4-Tetrahydroisoquinolines Derivatives as Monoamine Oxidase Inhibitors for Treatment of Alzheimer’s and Parkinson’s Diseases. Asian Journal of Chemistry. 27, 10 (Jun. 2015), 3651–3654. DOI:https://doi.org/10.14233/ajchem.2015.18903.